1. Pulmonary nocardiosis in cystic fibrosis
Shannon T. Thorn, Mark A. Brown, James J. Yanes, Duane L. Sherrill, Juliana Pugmire, K. Arbor Anderson, Stephen A. Klotz 
Journal of Cystic Fibrosis 
Volume 8, Issue 5, Pages (September 2009)
DOI: /j.jcf
Copyright © 2009 European Cystic Fibrosis Society. Terms and Conditions

2. Fig. 1
Averages of FEV1 values for each subject 180 days before and 180 days after antibiotic start date (start date=0) for each episode. The mean values for each subject are a different color. Two subjects did not receive antibiotics and were not included in this graph. The bold black line represents an aggregate of all patient values.
Journal of Cystic Fibrosis 2009 8, DOI: ( /j.jcf )
Copyright © 2009 European Cystic Fibrosis Society. Terms and Conditions

3. Fig. 2
Averages of FVC values for each subject 180 days before and 180 days after antibiotic start date (start date=0). The mean values for each subject are a different color. The bold black line represents an aggregate of all patient values.
Journal of Cystic Fibrosis 2009 8, DOI: ( /j.jcf )
Copyright © 2009 European Cystic Fibrosis Society. Terms and Conditions